healthcare

healthcare Articles

Epizyme shares jumped on Friday after the company announced a set of pipeline updates as well as a key update from the FDA.
Novavax shares jumped early on Friday after the company reported that its midstage flu vaccine had some positive results.
Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen for its treatment of secondary hyperparathyroidism in adult patients with chronic...
Catabasis shares jumped on Thursday after the company provided an update from its late-stage trial for edasalonexent in Duchenne muscular dystrophy.
Atara Biotherapeutics shares dipped on Thursday after the company provided a few business updates.
Sesen Bio shares took a beating on Thursday despite posting positive data for its late-stage trial for patients with high-grade non-muscle invasive bladder cancer.
DBV Technologies shares made a handy gain on Thursday after the company announced that it would be making some changes in its senior leadership ahead of its anticipated resubmission of its Viaskin...
Bristol-Myers has announced a definitive agreement to acquire rival Celgene in a cash and stock deal worth $74 billion. Celgene shareholders are scheduled to receive a 54% premium to Wednesday...
Merck shares were relatively unchanged early on Thursday after the firm announced that its blockbuster drug Keytruda reported a series of approvals in Japan.
Clinical-stage biotechnology company Stealth Biotherapeutics has filed with the SEC regarding its initial public offering.
Cara Therapeutics shares jumped on Wednesday after the firm announced a key update in its late-stage chronic kidney disease trial.
Immunotherapy company TCR2 Therapeutics has filed with the SEC regarding its initial public offering.
Initial public offerings and significant investment by established firms raised the valuations of several companies in the marijuana-related sector. Here are the 10 largest firms at the end of 2018.
Opko Health shares shot up on Friday after the firm announced that it has settled with the SEC with regard to charges against the company's CEO.
Clinical-stage immunotherapy company Harpoon Therapeutics has filed with the SEC for its initial public offering.